Arginine vasopressin: a promising rescue drug in the treatment of uncontrolled haemorrhagic shock

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 2, 2008, Pages 299-316

  Wenzel, Volker ^a   Raab, Helmut ^a   Dünser, Martin W ^b  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

arginine vasopressin; haemorrhagic shock; traumatic brain injury; uncontrolled; VITRIS

Indexed keywords

ADRENALIN; ARGIPRESSIN; CATECHOLAMINE; MANNITOL; NORADRENALIN; PHENYLEPHRINE; PLACEBO;

BLOOD TRANSFUSION; CLINICAL TRIAL; CONTINUOUS INFUSION; DEATH; DEFIBRILLATION; DRUG MECHANISM; DRUG TOLERABILITY; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; HEART ARREST; HEART MUSCLE ISCHEMIA; HEMORRHAGIC SHOCK; HEMOSTASIS; HORMONE RELEASE; HORMONE RESPONSE; HOSPITAL ADMISSION; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; VASOCONSTRICTION;

ANIMALS; ARGININE VASOPRESSIN; BRAIN INJURIES; CLINICAL TRIALS AS TOPIC; HUMANS; MULTIPLE TRAUMA; SHOCK, HEMORRHAGIC; VASOCONSTRICTOR AGENTS;

EID: 44949164419     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2008.02.003     Document Type: Review

References (65)

1. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349 (1997) 1498-1504
2. Guyton A.C., and Hall J.E. Circulatory shock and physiology of its treatment. In: Guyton A.C., and Hall J.E. (Eds). Textbook of medical physiology. 10th edn. (2000), W.B. Saunders, Philadelphia 253-262
3. Benedict C.R., and Grahame-Smith D.G. Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydoxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. The Quarterly Journal of Medicine 47 (1978) 1-20
4. Voelckel W., and Wenzel V. Managing hemorrhagic shock: fluids on the way - drugs on the way in?. Critical Care Medicine 31 (2003) 2552-2553
5. Dolich M., and Cohn S. Solutions for volume resuscitation in trauma patients. Current Opinion in Critical Care 5 (1999) 523-528
6. Cannon W., Fraser J., and Cowell E. The preventative treatment of wound shock. JAMA: The Journal of the American Medical Association 70 (1918) 618-621
7. Bickell W.H., Wall Jr. M.J., Pepe P.E., et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. The New England Journal of Medicine 331 (1994) 1105-1109
8. Kwan I., Brunn F., and Roberts I. Timing and volume of fluid administration for patients with bleeding. Cochrane Database of Systematic Reviews (Online) (2003) CD002245
9. Roberts I., Evans P., Bunn F., et al. Is the normalisation of blood pressure in bleeding trauma patients harmful?. Lancet 357 (2001) 385-387
10. Martinowitz U., Kenet G., Lubetski A., et al. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemrrhage associated with massive trauma. Canadian Journal of Anaesthesia 49 (2002) 15-20
11. Krismer A.C., Wenzel V., Lindner K.H., et al. Influence of negative expiratory pressure ventilation on hemodynamic variables during severe hemorrhagic shock. Critical Care Medicine 34 (2006) 2175-2181
12. Goodin T.H., Grossbard E.B., Kaufman R.J., et al. A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study. Critical Care Medicine 22 (1994) 680-689
13. Dunser M.W., Lindner K.H., and Wenzel V. Vasopressin: multitalented hormone among the shock hormones?. Critical Care Medicine 34 (2006) 562-564
14. Szabo C., and Salzman A.L. Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. Shock 5 (1996) 391-394
15. Safar P.J., and Tisherman S.A. Suspended animation for delayed resuscitation. Current Opinion in Anaesthesiology 15 (2002) 203-210
16. Nozari A., Safar P., Wu X., et al. Suspended animation can allow survival without brain damage after traumatic exsanguinations cardiac arrest of 60 minutes in dogs. The Journal of Trauma 57 (2004) 1266-1275
17. Lienhart H.G., Wenzel V., Braun J., et al. Vasopressin for therapy of persistent traumatic hemorrhagic shock. The Vitris.at Study. Anaesthesist 56 (2007) 145-150
18. Landry D.W., and Oliver J.A. The pathogenesis of vasodilatory shock. The New England Journal of Medicine 345 (2001) 588-595
19. Morales D., Madigan J., Cullinane S., et al. Reversal by vasopressin of intractable hypotension in the last phase of hemorrhagic shock. Circulation 100 (1999) 226-229
20. Fries D., Streif W., Haas T., and Kühbacher G. Dilutional coagulopathy, an underestimated problem?. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie 39 (2004) 745-750
21. Haisch G., Boldt J., Krebs C., et al. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia 15 (2001) 316-321
22. Deusch F., Gamsjäger T., Kress H.G., and Kozek-Langenecker S.A. Binding of hydroxyethyl starch molecules to the platelet surface. Anesthesia and Analgesia 97 (2003) 680-683
23. Holmes C.L., Landry D.W., and Granton J.T. Science review: vasopressin and the cardiovascular system part 1 - receptor physiology. Critical Care (London, England) 7 (2003) 427-434
24. Holmes C.L., Landry D.W., and Granton J.T. Science review: vasopressin and the cardiovascular system part 2 - clinical physiology. Critical Care (London, England) 8 (2004) 15-23
25. Guyton A.C., and Hall J.E. Hemostasis and blood coagulation. In: Guyton A.C., and Hall J.E. (Eds). Textbook of medical physiology. 10th edn. (2000), W.B. Saunders, Philadelphia 419-429
26. Seamon M.J., Fisher C.A., Gaughan J., et al. Prehospital procedures before emergency department thoracotomy: "scoop and run" saves lives. The Journal of Trauma 63 (2007) 113-120
27. Demetriades D., Martin M., Salim A., et al. The effect of trauma center designation and trauma volume on outcome in specific severe injuries. Annals of Surgery 242 (2005) 512-517
28. Demetriades D., Martin M., Salim A., et al. Relationship between American College of Surgeons trauma center designation and mortality in patients with severe trauma (injury severity score >15). Journal of the American College of Surgeons 202 (2006) 212-215
29. Ota K., Kimura T., Matsui K., et al. Effects of hemorrhage on vasopressin and Met-Enk release in blood and cerebrospinal fluid in dogs. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 255 (1988) 731-736
30. Mutlu G.M., and Factor P. Role of vasopressin in the management of septic shock. Intensive Care Medicine 30 (2004) 1276-1291
31. Hock C.E., Su J.Y., and Lefer A.M. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock. American Journal of Physiology. Heart and Circulatory Physiology 246 (1984) H174-H179
32. Westermann I., Dunser M.W., Haas T., et al. Endogenous vasopressin and copeptin response in multiple trauma patients. Shock (2007) [epub ahead of print]
33. Jochberger S., Mayr V.D., Luckner G., et al. Serum vasopressin concentrations in critically ill patients. Critical Care Medicine 34 (2006) 293-299
34. Sharshar T., Blanchard A., Paillard M., et al. Circulating vasopressin levels in septic shock. Critical Care Medicine 31 (2003) 1752-1758
35. Voelckel W., Lurie K.G., Lindner K.H., et al. Vasopressin improves survival after cardiac arrest in hypovolemic shock. Anesthesia and Analgesia 91 (2000) 627-634
36. Stadlbauer K.H., Wagner-Berger H.G., Raedler C., et al. Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal and hemorrhagic shock in pigs. Anesthesiology 98 (2003) 699-704
37. Voelckel W.G., Raedler C., Wenzel V., et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Critical Care Medicine 31 (2003) 1160-1165
38. Raedler C., Voelckel W.G., Wenzel V., et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesthesia and Analgesia 98 (2004) 1759-1766
39. Johnson K.B., Pearce F.J., Jeffreys N., et al. Impact of vasopressin on hemodynamic and metabolic function in the decompensatory phase of hemorrhagic shock. Journal of Cardiothoracic and Vascular Anesthesia 20 (2006) 167-172
40. Yoo J.H., Kim M.S., and Park H.M. Hemodynamic characteristics of vasopressin in dogs with severe hemorrhagic shock. The Journal of Veterinary Medical Science 68 (2006) 967-972
41. Yoo J.H., Kim M.S., Eom K.D., et al. Vasopressor therapy using vasopressin prior to crystalloid resuscitation in irreversible hemorrhagic shock under isoflurane anesthesia in dogs. The Journal of Veterinary Medical Science 69 (2007) 459-464
42. Cheung A.T., To P.L., Chan D.M., et al. Comparison of treatment modalities for hemorrhagic shock. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 35 (2007) 173-190
43. Driessen B., Zarucco L., Gunther R.A., et al. Effects of low-volume haemoglobin glutamer-200 versus normal saline and arginine vasopressin resuscitation on systemic and skeletal muscle blood flow and oxygenation in a canine hemorrhagic shock model. Critical Care Medicine 35 (2007) 2221-2227
44. Cohn S.M. Potential benefit of vasopressin in resuscitation of hemorrhagic shock. The Journal of Trauma 68 (2007) 56-57
45. Goff J.S. Gastroesophageal varices: pathogenesis and therapy of acute bleeding. Gastroenterology Clinics of North America 22 (1993) 779-800
46. Haas T., Voelckel W., Wiedermann F., et al. Successful resuscitation of a traumatic cardiac arrest victim in hemorrhagic shock with vasopressin: a case report and brief review of the literature. The Journal of Trauma 57 (2004) 177-179
47. Krismer A.C., Wenzel V., Voelckel W.G., et al. Applying vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature. Der Anaesthesist 54 (2005) 220-224
48. Sharma R.M., and Setlur R. Vasopressin in hemorrhagic shock. Anesthesia and Analgesia 101 (2005) 833-834
49. Yeh C.C., Wu C.T., Lu C.H., et al. Early use of small-dose vasopressin for unstable hemodynamics in an acute brain injury patient refractory to catecholamine treatment: a case report. Anesthesia and Analgesia 97 (2003) 577-579
50. Meyer S., Gottschling S., and Gortner L. The use of terlipressin in a 14-year old adolescent with catecholamine-resistant shock after severe traumatic brain injury. Acta Anaesthesiologica Scandinavica 51 (2007) 957
51. Salluh J.I., Martins G.A., Santino M.S., et al. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury. Acta Anaesthesiologica Scandinavica 51 (2007) 505-508
52. Feinstein A.J., Patel M.B., Sanui M., et al. Resuscitation with pressors after traumatic brain injury. Journal of the American College of Surgeons 201 (2005) 536-545
53. Sanui M., King D.R., Feinstein A.J., et al. Effects of arginine vasopressin during resuscitation from hemorrhagic hypotension after traumatic brain injury. Critical Care Medicine 34 (2006) 433-438
54. Meybohm P., Cavus E., Bein B., et al. Small volume resuscitation: a randomized controlled trial with either norepinephrine or vasopressin during severe hemorrhage. The Journal of Trauma 62 (2007) 640-646
55. Meybohm P., Cavus E., Dorges V., et al. Release of protein S100B in haemorrhagic shock: effects of small volume resuscitation combined with arginine vasopressin. Resuscitation (2007) [epub ahead of print]
56. Back S.M., and Kim S.S. Successful digital replantation after 42 hours of warm ischemia. Journal of Reconstructive Microsurgery 8 (1992) 455-458
57. Nissenson A.R. Acute renal failure: definition and pathogenesis. Kidney International. Supplement 66 (1998) S7-S10
58. Henrion J., Schapira M., Luwaert R., et al. Hypoxic hepatitis - Clinical and hemodynamic study in 142 consecutive cases. Medicine 82 (2003) 392-406
59. Lock G., and Schölmerich J. Non-occlusive mesenteric ischemia. Hepato-gastroenterology 42 (1995) 234-239
60. Deitch E.A., and Dayal S.D. Intensive care unit management of the trauma patient. Critical Care Medicine 34 (2006) 2294-2301
61. Elster E. Trauma and the immune response: strategies for success. The Journal of Trauma 62 (2007) S54-S55
62. Shelly M.P., Greatorex R., Calme R.Y., and Park G.R. The physiological effects of vasopressin when used to control intra-abdominal bleeding. Intensive Care Medicine 14 (1988) 526-531
63. Mayr V.D., Wenzel V., Müller T., et al. Effects of vasopressin on left anterior descending coronary artery blood flow during extremely low cardiac output. Resuscitation 62 (2004) 229-235
64. Wenzel V., Krismer A.C., Arntz H.R., et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. The New England Journal of Medicine 350 (2004) 105-113
65. Luckner G., Dünser M.W., Jochberger S., et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Critical Care Medicine 33 (2005) 2659-2666